Tissue microarray construction from bone marrow biopsies

BioTechniques

Volumn 39, Issue 6, 2005, Pages 822-824

  Obermann, Ellen C ^a   Marienhagen, Joerg ^a   Stoehr, Robert ^a   Wuensch, Peter H ^b   Hofstaedter, Ferdinand ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Nuremberg Clinic Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; TISSUE MICROARRAY; BIOPSY; BONE MARROW; HUMAN; METHODOLOGY; PATHOLOGY;

BIOPSY; BONE MARROW; HUMANS; TISSUE ARRAY ANALYSIS;

EID: 33644799486     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112073     Document Type: Article

References (13)

1. Bubendorf, L., J. Kononen, P. Koivisto, P. Schraml, H. Moch, T.C. Gasser, N. Willi, M.J. Mihatsch, et al. 1999. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res. 59:803-806.
2. Kononen, J., L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, et al. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:844-847.
3. Barlund, M., F. Forozan, J. Kononen, L. Bubendorf, Y. Chen, M.L. Bittner, J. Torhorst, P. Haas, et al. 2000. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J. Natl. Cancer Inst. 92:1252-1259.
4. Bubendorf, L., M. Kolmer, J. Kononen, P. Koivisto, S. Mousses, Y. Chen, E. Mahlamaki, P. Schraml, et al. 1999. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J. Natl. Cancer Inst. 97:1758-1764.
5. Bubendorf, L., A. Nocito, H. Moch, and G. Sauter. 2001. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J. Pathol. 195:72-79.
6. Kallioniemi, O.P., U. Wagner, J. Kononen, and G. Sauter. 2001. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet. 10:657-662.
7. Packeisen, J., E. Korsching, H. Herbst, W. Boecker, and H. Buerger. 2003. Demystified...tissue microarray technology. Mol. Pathol. 56:198-204.
8. Tzankov, A., A. Zimpfer, A.C. Pehrs, A. Lugli, P. Went, R. Maurer, S. Pileri, and S. Dirnhofer. 2003. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod. Pathol. 16:1141-1147.
9. Mengel, M., H. Kreipe, and R. Von Wasielewski. 2003. Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl. Immunohistochem. Mol. Morphol. 11:261-268.
10. Camp, R.L., L.A. Charette, and D.L. Rimm. 2000. Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80:1943-1949.
11. Endl, E., C. Hollmann, and J. Gerdes. 2001. Antibodies against the Ki-67 protein: assessment of the growth fraction and tools for cell cycle analysis. Methods Cell Biol. 63:399-418.
12. Stoeber, K., T.D. Tlsty, L. Happerfield, G.A. Thomas, S. Romanov, L. Bobrow, E.D. Williams, and G.H. Williams. 2001. DNA replication licensing and human cell proliferation. J. Cell Sci. 114:2027-2041.
13. Schraml, P., C. Bucher, H. Bissig, A. Nocito, P. Haas, K. Wilber, S. Seelig, J. Kononen, et al. 2003. Cyclin E overexpression and amplification in human tumours. J. Pathol. 200:375-382.